Power Index Rank #164
Eli Lilly
COMPANY · Entity tracked in the LeadersCartel Power Index
1
/ 100
DOMINANT
0
High Signals
2
Emerging
0
Watch
0
Weak
Intelligence Brief
Eli Lilly holds a monitored position in the LeadersCartel Power Index at rank #167 with a score of 0.7/100. Signal intelligence tracks Eli Lilly across 30 sources with 0H/2E/0W active signal distribution.
Key developments include: Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss dru, and A high dose of Wegovy will cost $50 less than Zepbound.
Eli Lilly maintains significant linkage with Novo Nordisk, Lumentum, OPEC across shared intelligence signals.
Analysis updated April 12, 2026 at 08:00 UTC · Powered by RAVEN
Influence Sectors
Trade
Active Intelligence Signals
• EMERGING0.85
Nvidia AI Infrastructure Crisis: VP Reports Team Complaints Over AI Tool Limitations Despite Massive Investment; Semiconductor Sector Faces Capacity Constraints
Nvidia Vice President acknowledged that teams heavily integrated into AI workflows have significant complaints about tool trustworthiness and performance, even as the semiconductor giant pursues massi
• EMERGING0.65
Eli Lilly Market Share Declines as Novo Nordisk Holds Ground; Generic Weight-Loss Drugs Flood Indian Market
Eli Lilly's market share has contracted while Novo Nordisk maintains its position as generic weight-loss medications proliferate in the Indian pharmaceutical market. The competitive dynamics reflect b